Literature DB >> 6983682

The bacteriology and cytology of chronic otitis media with effusion.

G S Giebink, S K Juhn, M L Weber, C T Le.   

Abstract

The bacteriology and cytology of middle ear effusion from 729 children with persistent otitis media with effusion were studied. Thirty-five percent of these chronic effusions were culture-positive. Type b and non-type b Haemophilus influenzae, Streptococcus pneumoniae, Neisseria sp. and Staphylococcus epidermidis were the predominant isolates. Serous and mucoid effusion cultures yielded bacteria more often in younger than in older children. In addition bacteria were seen in 17% of the Gram-stained smears of the sterile effusions; Gram-positive cocci predominated in these effusions. Disparate effusion culture results were obtained in 32% of bilateral otitis media cases. Effusions which yielded H. influenzae and S. pneumoniae on culture had more polymorphonuclear leukocytes than did effusions which yielded S. epidermidis or Neisseria or were sterile. Phagocytic cells were equally prevalent in sterile effusions with or without bacteria on Gram stain. Phagocytic cells were seen less often in mucoid effusions from antibiotic-treated patients than in mucoid effusions from untreated patients. The results suggest that certain bacteria in chronic middle ear effusion contribute to the pathogenesis of this condition by eliciting a local inflammatory cell response.

Entities:  

Mesh:

Year:  1982        PMID: 6983682     DOI: 10.1097/00006454-198203000-00007

Source DB:  PubMed          Journal:  Pediatr Infect Dis        ISSN: 0277-9730


  15 in total

1.  Adherence of Haemophilus influenzae to nasal, nasopharyngeal and buccal epithelial cells from patients with otitis media.

Authors:  T Harada; Y Sakakura; C S Jin
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

2.  Penicillin treatment accelerates middle ear inflammation in experimental pneumococcal otitis media.

Authors:  M Kawana; C Kawana; G S Giebink
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

3.  Role of the bacterial cell wall in middle ear inflammation caused by Streptococcus pneumoniae.

Authors:  B D Carlsen; M Kawana; C Kawana; A Tomasz; G S Giebink
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

Review 4.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

5.  Recovery of a unique bacterial organism in human middle ear fluid and its possible role in chronic otitis media.

Authors:  H Faden; D Dryja
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

Review 6.  Biofilms: survival mechanisms of clinically relevant microorganisms.

Authors:  Rodney M Donlan; J William Costerton
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

7.  Effect of modulation of polymorphonuclear leukocyte migration with anti-CD18 antibody on pathogenesis of experimental otitis media in guinea pigs.

Authors:  J Patel; T Chonmaitree; F Schmalstieg
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

8.  High incidence of Haemophilus influenzae in nasopharyngeal secretions and middle ear effusions as detected by PCR.

Authors:  T Ueyama; Y Kurono; K Shirabe; M Takeshita; G Mogi
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

9.  Roles of autolysin and pneumolysin in middle ear inflammation caused by a type 3 Streptococcus pneumoniae strain in the chinchilla otitis media model.

Authors:  K Sato; M K Quartey; C L Liebeler; C T Le; G S Giebink
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

10.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.